Unknown

Dataset Information

0

Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes.


ABSTRACT: Bariatric surgery improves glycemic control better than medical therapy; however, the effect of bariatric surgery on HDL function is not well characterized. Serum samples were available at baseline, 1-, and 5-years post procedures, for 90 patients with obesity and type 2 diabetes who were randomized to intensive medical therapy (n = 20), Roux-en-Y gastric bypass (RYGB, n = 37), or sleeve gastrectomy (SG, n = 33) as part of the STAMPEDE clinical trial. We examined serum HDL function by two independent assays, apolipoprotein A-1 exchange rate (AER) and cholesterol efflux capacity (CEC). Compared with baseline, AER was significantly higher at 5 years for participants in all treatment groups, but only increased significantly at 1 year in the RYGB and SG groups. CEC was divided into ABCA1-dependent and independent fractions, and the later was correlated with AER. ABCA1-independent CEC increased significantly only at 5 years in both surgical groups, but did not significantly change in the medical therapy group. There was no significant change in ABCA1-dependent CEC in any group. The increase in AER, but not ABCA1-independent CEC, was correlated with the reduction in body mass index and glycated hemoglobin levels among all subjects at 5 years, indicating that AER as a measure of HDL function would be a better reflection of therapy versus CEC.

SUBMITTER: Lorkowski SW 

PROVIDER: S-EPMC7226587 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes.

Lorkowski Shuhui Wang SW   Brubaker Gregory G   Rotroff Daniel M DM   Kashyap Sangeeta R SR   Bhatt Deepak L DL   Nissen Steven E SE   Schauer Philip R PR   Aminian Ali A   Smith Jonathan D JD  

Biomolecules 20200404 4


Bariatric surgery improves glycemic control better than medical therapy; however, the effect of bariatric surgery on HDL function is not well characterized. Serum samples were available at baseline, 1-, and 5-years post procedures, for 90 patients with obesity and type 2 diabetes who were randomized to intensive medical therapy (<i>n</i> = 20), Roux-en-Y gastric bypass (RYGB, <i>n</i> = 37), or sleeve gastrectomy (SG, <i>n</i> = 33) as part of the STAMPEDE clinical trial. We examined serum HDL f  ...[more]

Similar Datasets

| S-EPMC4308988 | biostudies-literature
| S-EPMC3697153 | biostudies-literature
| S-EPMC3540842 | biostudies-literature
| S-EPMC7887026 | biostudies-literature
| S-EPMC4513993 | biostudies-literature
| S-EPMC6223079 | biostudies-literature
| S-EPMC5516727 | biostudies-literature
| S-EPMC7901093 | biostudies-literature
| S-EPMC9598682 | biostudies-literature
| S-EPMC10357319 | biostudies-literature